Semaphorin-PlexinD1 Signaling Limits Angiogenic Potential via the VEGF Decoy Receptor sFlt1 von Zygmunt, Tomasz, Gay, Carl Michael, Blondelle, Jordan, Singh, Manvendra K., Flaherty, Kathleen McCrone, Means, Paula Casey, Herwig, Lukas, Krudewig, Alice, Belting, Heinz-Georg, Affolter, Markus, Epstein, Jonathan A., Torres-Vázquez, Jesús

Volltext

A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers von Zhang, Bingnan, Ramkumar, Kavya, Cardnell, Robert John, Gay, Carl Michael, Stewart, C. Allison, Wang, Wei-Lien, Fujimoto, Junya, Wistuba, Ignacio I., Byers, Lauren Averett

Volltext

Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC von Della Corte, Carminia Maria, Ciaramella, Vincenza, Ramkumar, Kavya, Vicidomini, Giovanni, Fiorelli, Alfonso, Nardone, Valerio, Cappabianca, Salvatore, Cozzolino, Immacolata, Zito Marino, Federica, Di Guida, Gaetano, Wang, Qi, Cardnell, Robert, Gay, Carl Michael, Ciardiello, Davide, Martinelli, Erika, Troiani, Teresa, Martini, Giulia, Napolitano, Stefania, Wang, Jing, Byers, Lauren Averett, Ciardiello, Fortunato, Morgillo, Floriana

Volltext

Clinical outcomes of chemotherapy rechallenge in patients with metastatic non-small cell lung (NSCLC) who progressed on immunotherapy maintenance after front line platinum doublets... von Wang, Kaiwen, Fossella, Frank V., Negrao, Marcelo Vailati, Cascone, Tina, Gay, Carl Michael, Le, Xiuning, Vokes, Natalie I, Bueno Hume, Celyne, Hassan, Amy Aida, Gibbons, Don Lynn, Lee, J. Jack, Heymach, John, Zhang, Jianjun

Volltext

A phase I-III platform study evaluating the safety and efficacy of multiple therapies in patients with biomarker-defined locally advanced, unresectable stage III non–small-cell lun... von Paz-Ares, Luis G., Gay, Carl Michael, Zhou, Caicun, Kato, Terufumi, Corrales, Luis, Redhead, Karl, Rahman, Ahmadur, Bradley, Denise, Theogaraj, Elizabeth, Hutchinson, Katherine E., Shagan, Sarah M., Solomon, Benjamin J.

Volltext

Driver mutations to predict for poorer outcomes in non-small cell lung cancer patients treated with concurrent chemoradiation and consolidation durvalumab von Liu, Yufei, Zhang, Zhe, Rinsurongkawong, Waree, Le, Xiuning, Gay, Carl Michael, Ning, Matthew S., Heymach, John, Zhang, Jianjun, Lin, Steven H.

Volltext

SWOG S2012: Randomized phase II/III trial of first line platinum/etoposide (P/E) with or without atezolizumab (NSC#783608) in patients (pts) with poorly differentiated extrapulmona... von Zhen, David Bing, Mayerson, Edward, Chiorean, E. Gabriela, Burgess, Earle F, Swisher, Elizabeth M., Gay, Carl Michael, Byers, Lauren Averett, Wistuba, Ignacio Ivan, Mahdi, Haider, Das, Satya, Starr, Jason S., Othus, Megan, Chae, Young Kwang, Kurzrock, Razelle

Volltext

Results of a phase 1b study of osimertinib plus sapanisertib or alisertib for osimertinib-resistant, EGFR-mutant non–small cell lung cancer (NSCLC) von Elamin, Yasir Y, Negrao, Marcelo Vailati, Fossella, Frank V., Byers, Lauren Averett, Zhang, Jianjun, Gay, Carl Michael, Tu, Janet Chen, Pozadzides, Jenny Vu, Tran, Hai T., Lu, Charles, Feng, Lei, Spelman, Amy R., Blumenschein, George R., Tsao, Anne S., Heymach, John

Volltext

Analysis of tumor- and circulating-free DNA methylation to identify clinically relevant small cell lung cancer subtypes von Heeke, Simon, Gay, Carl Michael, Estecio, Marcos Roberto, Tran, Hai T., Morris, Benjamin B., Zhang, Bingnan, Tang, XiMing, Raso, Maria G, Rocha, Pedro, Arriola, Edurne, Hofman, Paul, Kopparapu, Prasad, Lovly, Christine M., Concannon, Kyle, Xi, Yuanxin, Diao, Lixia, Wang, Qi, Wang, Jing, Byers, Lauren Averett, Heymach, John

Volltext

SWOG S1929: Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer... von Abdel Karim, Nagla Fawzy, Miao, Jieling, Reckamp, Karen L., Gay, Carl Michael, Byers, Lauren Averett, Zhao, Yingqi, Redman, Mary Weber, Carrizosa, Daniel R., Wang, Wei-Lien, Petty, William J., Mehta, Kathan, Faller, Bryan A., Agamah, Edem S., Kasbari, Samer S., Malisetti, Rajini Katipamula, Kumar, Atul, Schallenkamp, John, Alluri, Krishna Chaitanya, Gray, Jhanelle Elaine, Kelly, Karen

Volltext

Longitudinal tracking of ALK -positive lung cancer from plasma using circulating-tumor RNA and circulating-tumor DNA in the BRIGHTSTAR clinical trial von Heeke, Simon, Gandhi, Saumil, Tran, Hai T., Lam, Vincent K., Byers, Lauren Averett, Gibbons, Don Lynn, Gay, Carl Michael, Altan, Mehmet, Antonoff, Mara, Le, Xiuning, Tu, Janet Chen, Pek, Michelle, Poh, Jonathan, Ngeow, Kao Chin, Tsao, Anne S., Cascone, Tina, Negrao, Marcelo Vailati, Blumenschein, George R., Heymach, John, Elamin, Yasir Y

Volltext

Clinical outcome and potential benefits of post-progression immunotherapy for patients with metastatic NSCLC with primary resistance to ipilumumab and nivolumab in the LONESTAR pha... von Altan, Mehmet, Sui, Dawen, Gandhi, Saumil, Swisher, Stephen, Vokes, Natalie I, Antonoff, Mara, Zhang, Jianjun, Blumenschein, George R., Cascone, Tina, Elamin, Yasir Y, Gay, Carl Michael, Gibbons, Don Lynn, Le, Xiuning, Negrao, Marcelo Vailati, Skoulidis, Ferdinandos, Tsao, Anne S., Tu, Janet Chen, Spelman, Amy R., Lee, J. Jack, Heymach, John

Volltext

Abstract 3854: TNIK inhibition as a novel therapeutic in cMyc high/TTF1 low SCLC von Tanimoto, Azusa, Cardnell, Robert J., Morris, Benjamin B., Ramkumar, Kavya, Li, Shen, Wang, Qi, Stewart, Allison C., Gay, Carl Michael, Wang, Jing, Averett Byers, Lauren

Volltext

ILK and SHP2 expression identify a poor prognostic cohort of EGFR-mutant lung cancer von Della Corte, Carminia Maria, Gay, Carl Michael, Byers, Lauren Averett, Morgillo, Floriana

Volltext

Semaphorin-PlexinD1 Signaling Limits Angiogenic Potential via the VEGF Decoy Receptor sFIt1 von ZYGMUNT, Tomasz, GAY, Carl Michael, EPSTEIN, Jonathan A, TORRES-VAZQUEZ, Jesus, BLONDELLE, Jordan, SINGH, Manvendra K, MCCRONE FLAHERTY, Kathleen, CASEY MEANS, Paula, HERWIG, Lukas, KRUDEWIG, Alice, BELTING, Heinz-Georg, AFFOLTER, Markus

Volltext

Integrative Molecular Characterization of Malignant Pleural Mesothelioma von Hmeljak, Julija, Sanchez-Vega, Francisco, Hoadley, Katherine A, Shih, Juliann, Stewart, Chip, Heiman, David, Tarpey, Patrick, Danilova, Ludmila, Drill, Esther, Gibb, Ewan A, Bowlby, Reanne, Kanchi, Rupa, Osmanbeyoglu, Hatice U, Sekido, Yoshitaka, Takeshita, Jumpei, Newton, Yulia, Graim, Kiley, Gupta, Manaswi, Gay, Carl M, Diao, Lixia, Gibbs, David L, Thorsson, Vesteinn, Iype, Lisa, Kantheti, Havish, Severson, David T, Ravegnini, Gloria, Desmeules, Patrice, Jungbluth, Achim A, Travis, William D, Dacic, Sanja, Chirieac, Lucian R, Galateau-Sallé, Françoise, Fujimoto, Junya, Husain, Aliya N, Silveira, Henrique C, Rusch, Valerie W, Rintoul, Robert C, Pass, Harvey, Kindler, Hedy, Zauderer, Marjorie G, Kwiatkowski, David J, Bueno, Raphael, Tsao, Anne S, Creaney, Jenette, Lichtenberg, Tara, Leraas, Kristen, Bowen, Jay, Felau, Ina, Zenklusen, Jean Claude, Akbani, Rehan, Cherniack, Andrew D, Byers, Lauren A, Noble, Michael S, Fletcher, Jonathan A, Robertson, A Gordon, Shen, Ronglai, Aburatani, Hiroyuki, Robinson, Bruce W, Campbell, Peter, Ladanyi, Marc

Volltext

Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironme... von Sen, Triparna, Della Corte, Carminia M., Milutinovic, Snezana, Cardnell, Robert J., Diao, Lixia, Ramkumar, Kavya, Gay, Carl M., Stewart, C. Allison, Fan, Youhong, Shen, Li, Hansen, Ryan J., Strouse, Bryan, Hedrick, Michael P., Hassig, Christian A., Heymach, John V., Wang, Jing, Byers, Lauren A.

Volltext

Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas von Abeshouse, Adam, Armenia, Joshua, Auman, J. Todd, Bailey, Matthew H., Baker, Laurence, Balasundaram, Miruna, Balu, Saianand, Baylin, Stephen B., Behera, Madhusmita, Benz, Christopher, Bocklage, Thèrése, Boice, Lori, Bootwalla, Moiz S., Bowlby, Reanne, Boyd, Jeff, Castro, Patricia, Cherniack, Andrew D., Chudamani, Sudha, Cooper, Lee A.D., Davis, Ian J., Demetri, George D., Demicco, Elizabeth G., Ding, Li, DiSaia, Phil, Dottino, Peter, Eschbacher, Jennifer, Fedosenko, Konstantin, Ferguson, Martin L., Gao, Qingsong, Gastier-Foster, Julie M., Gerken, Mark, Godwin, Eryn M., Gordienko, Elena, Grilley-Olson, Juneko E., Gutman, David A., Hegde, Apurva M., Heiman, David I., Helsel, Carmen, Hoadley, Katherine A., Hobensack, Shital, Hornick, Jason L., Hoyle, Alan P., Iacocca, Mary, Ittmann, Michael, Jones, Steven J.M., Kim, Jaegil, Ladanyi, Marc, Lai, Phillip H., Larsson, Erik, Lee, Sanghoon, Lehmann, Kjong-Van, Levine, Douglas A., Liu, Jia, Liu, Wenbin, Liu, Eric Minwei, Lu, Yiling, Madan, Rashna, Magliocco, Anthony, Maki, Robert G., Martinez, Cathleen, Mayo, Michael, McLellan, Michael D., Mozgovoy, Evgeny, Mungall, Andrew J., Mungall, Karen, Noble, Michael S., Olvera, Narciso, Paklina, Oxana, Paulauskis, Joseph, Penny, Robert, Perou, Charles M., Perou, Amy H., Pollock, Raphael E., Ramalingam, Suresh S., Reilly, Colleen, Reynolds, Sheila M., Roach, Jeffrey, Roszik, Jason, Sadeghi, Sara, Saksena, Gordon, Sanchez-Vega, Francisco, Sander, Chris, Schein, Jacqueline E., Shelton, Candace, Shelton, Troy, Shi, Yan, Shmulevich, Ilya, Sipahimalani, Payal, Swanson, Patricia, Tarnuzzer, Roy, Thiessen, Nina, Thorne, Leigh B., Van Tine, Brian A., Verhaak, Roel, Voronina, Olga, Wang, Jing, Wise, Lisa, Wyczalkowski, Matthew, Yau, Christina, Yellapantula, Venkata

Volltext

Effectiveness of a national quality improvement programme to improve survival after emergency abdominal surgery (EPOCH): a stepped-wedge cluster-randomised trial von Stephens, Tim, Kahan, Brennan, Brett, Stephen, Ackland, Gareth, Everingham, Kirsty, Abraham, Ajit, Gillies, Michael, Anderson, Iain, Drake, Sharon, Girling, Alan, Faiz, Omar, Blunt, Mark, Cabreros, Leilani, Obideyi, Ayodele, Brodbeck, Andreas, Gay, Mike, Pushpa, Nathan, Noble, Paul, Van De Velde, Niko, Singh, Satish, Gerstina, Nabua, Kuldip, Rai, Murray, Therese, Aryal, Kamal, Moncaster, Gareth, Abercrombie, John, Wells, John, Natarajan, Nat, Doughan, Samer, Mackinnon, John, Lawton, Greg, Watson, Mark, Stacey, Brenda, Fletcher, Steve, Prestwich, Stewart, Sharma, Abhiram, Hill, Oliver, Rose, Alastair, Narula, Harjeet, Buckley, Sarah, Dowling, Susan, Robin, Nicole, Januszewska, Marta, Bodger, Phoebe, Abbott, Tom, Full, Jens, Rehman, Almas, Mohr, Otto, Mateo, Dolores, Machesney, Michael, Borgeaud, Nathan, Harwood, Elizabeth, Moonesinghe, Ramani, Rafi, Amir, McNelis, Una, Roy, Alistair, Rimmer, Catherine, Monkhouse, Diane, Bhowmick, Arnab, Mcmullan, Sean, Doyle, Donna, Patel, Panna, Stergios, Tezas, Coldwell, Chris, Bronder, Christine, Stotz, Martin, Sugavanam, Anita, Tan, Melanie, Vashisht, Shubha, Vaganov, Sergei, Liasis, Lampros, Husain, Tariq, Baxter, Linden, Wilson, Chris, Williams, Dewi, Taylor, Lynn, Dickinson, Natalie, Gibson, Simon, Tan, Kerwei, Stevenson, Richard, Carey, Kate, Razouk, Khaled, Girgis, Amira, Somasekar, Krishnamurthy, Morgan-Jones, Tom, Martin, Michael, Watters, Malcolm, Sunthareswaran, Rame, Bell, Louise, Nash, Guy, Christie, Iain, Patrick, Abigail, Hanousek, Jan, Paddle, Jonathan, Pickford, Alison, Tucker, Olga, Leno, Emma, Colley, Julie, Wollaston, Julie, Singh, Jagdeep

Volltext

Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced n... von Corrigan, Kelsey L., Xu, Ting, Sasaki, Yuki, Lin, Ruitao, Chen, Aileen B., Welsh, James W., Lin, Steven H., Chang, Joe Y., Ning, Matthew S., Gandhi, Saumil, O'Reilly, Michael S., Gay, Carl M., Altan, Mehmet, Lu, Charles, Cascone, Tina, Koutroumpakis, Efstratios, Sheshadri, Ajay, Zhang, Xiaodong, Liao, Li, Zhu, X. Ronald, Heymach, John V., Nguyen, Quynh-Nhu, Liao, Zhongxing

Volltext